InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001179110-22-002053 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-03-08 2022-03-04 TDOC GOREVIC JASON N CEO, Dir M - OptEx — +38.6K 494.7K +8% —
DM 2022-03-08 2022-03-04 TDOC GOREVIC JASON N CEO, Dir M - OptEx $0.00 -38.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-04 M A 21,812 — 516,464 D — — (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2022-03-04 M A 16,778 — 494,652 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Derivative Performance Stock Units 2022-03-04 M D 21,812 $0.00 0 D — · — to — 21,812 Common Stock (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On February 26, 2020, the reporting person earned 65,435 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020.
4 Derivative Restricted Stock Units 2022-03-04 M D 16,778 $0.00 0 D — · — to — 16,778 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 4, 2019, the reporting person was granted 50,333 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.